|
Volumn 520, Issue 7547, 2015, Pages 389-393
|
Cancer: A most exceptional response
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NUCLEIC ACID;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);
TRANSCRIPTOME;
BIOINFORMATICS;
CANCER;
CHEMOTHERAPY;
GENOMICS;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNOASSAY;
MUTATION;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADVANCED CANCER;
ALGORITHM;
BIOCHEMISTRY;
COMMUNITY;
DNA METHYLATION;
DRUG INDUCED CANCER;
GENOME ANALYSIS;
HUMAN;
IMMUNOLOGIST;
MEDICAL RECORD;
NATIONAL HEALTH ORGANIZATION;
PRIORITY JOURNAL;
SCIENTIST;
SHORT SURVEY;
UNITED STATES;
FEMALE;
GENETIC DATABASE;
GENETIC SCREENING;
GENETICS;
LABORATORY DIAGNOSIS;
MEDICAL RESEARCH;
METABOLISM;
NEOPLASMS;
NUCLEOTIDE SEQUENCE;
PATHOLOGY;
PERSONALIZED MEDICINE;
PILOT STUDY;
PROCEDURES;
REMISSION;
SURVIVOR;
TRENDS;
BIOMEDICAL RESEARCH;
DATABASES, GENETIC;
DNA MUTATIONAL ANALYSIS;
FEMALE;
GENETIC TESTING;
HUMANS;
INDIVIDUALIZED MEDICINE;
NEOPLASMS;
PILOT PROJECTS;
REMISSION INDUCTION;
SPECIMEN HANDLING;
SURVIVORS;
|
EID: 84928403539
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/520389a Document Type: Short Survey |
Times cited : (16)
|
References (6)
|